http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5352596-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a6a9431aa1fe5109ca95ad4e332231b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-948
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16721
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
filingDate 1992-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1994-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c91803ad4d306c68b28c5ead460e34e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bdc346ca88d84daf4746e5ff2b15dc7
publicationDate 1994-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5352596-A
titleOfInvention Pseudorabies virus deletion mutants involving the EPO and LLT genes
abstract An attenuated pseudorabies virus (PRV) having a reduced ability to reactivate from latency is produced by introducing (1) a genomic modification in the early protein 0 (EP0) gene whereby said virus is characterized by the inability to express the early protein 0; or (2) a genomic modification in the large latency transcript (LLT) gene whereby said virus is characterized by disruption of the synthesis of said large latency transcript; or (3) the genomic modifications described in both (1) and (2). The attenuated virus is useful in a vaccine for psuedorabies-susceptible animals, particularly swine. Swine vaccinated with a deletion mutant in the EP0/LLT overlap region displayed reduced virus shedding and fewer clinical signs than animals inoculated with a wild type virus. The deletion mutant-vaccinated swine also harbored less PRV DNA in the nervous tissue and showed reduced ability to reactivate the virus.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011230404-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004106589-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0011014-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8552054-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014190838-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8563687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8871468-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006252120-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7199151-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6627601-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8314077-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9650424-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010261874-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006026719-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9006410-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2002301020-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007039073-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6077661-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6548642-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008242834-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6225444-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006148680-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004180949-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004009557-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003236111-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7816398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004009555-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008125380-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005074838-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008262198-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8623812-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6602902-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011217766-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7378506-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002177609-A1
priorityDate 1992-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8701287-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0141458-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4711850-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4514497-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4514497-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743

Total number of triples: 61.